首页> 外文期刊>Journal of theoretical & computational chemistry >Theoretical study on the binding of the anticancer drugs cis/trans-[ptcl5_2(nh_3){hn = c(ch_3) 2}] and cis/trans-[ptcl_2{hn = c(ch_3)_2}_2] to purine bases
【24h】

Theoretical study on the binding of the anticancer drugs cis/trans-[ptcl5_2(nh_3){hn = c(ch_3) 2}] and cis/trans-[ptcl_2{hn = c(ch_3)_2}_2] to purine bases

机译:抗癌药物顺/反-[ptcl5_2(nh_3){hn = c(ch_3)2}]和顺/反-[ptcl_2 {hn = c(ch_3)_2} _2] _2]与嘌呤碱基结合的理论研究

获取原文
获取原文并翻译 | 示例
           

摘要

The monofunctional (the first substitution reactions) and bifunctional (the second substitution reactions) binding of the title antitumor drugs to purine bases were studied computationally by using density functional theory and IEF-PCM solvation models. For the first substitutions with guanine and adenine, our calculations demonstrate that the trans monoaqua and diaqua reactant complexes (RCs) can generate trans- or cis-monoadducts via identical or very similar trigonal-bipyramidal transition-state structures, predicting that the cis-monoadducts generated by trans RCs can subsequently close by coordination to the adjacent purine bases to form 1,2-intrastrand Pt-DNA adducts and eventually distort DNA in the same way as cisplatin. Thus it is likely that the transplatin analogues have the same mechanism of anticancer activity of cisplatin. In general, the monoaqua and diaqua monofunctional substitutions prefer guanine over adenine. The calculated lowest activation free energy in aqueous solution is 15.2 kcal/mol in the monoaqua substitutions (substituted by guanine from trans-[Pt{HN = C(CH_3)_2}_2Cl(H_2O)]~+ to trans/cis-monoadduct), and 11.4 kcal/mol in the diaqua substitutions (substituted by guanine from cis-[Pt{HN = C(CH_3)2}_2(H_2O)_2]~(2+) to cis-monoadduct). For the second substitutions, all the reactants are started from the diaqua product complexes of the first substitutions substituted by guanine. The data obtained for the complexation energy difference between guanine and adenine RCs suggest that a thermodynamic favors the formation of GG over GA adducts by ~ 5 - 12 kcal/mol in aqueous solution. Moreover, there is a kinetic preference for the formation of GG over GA adduct for the cis-monoadduct to cis-diadduct paths, while for the trans-monoadduct to trans-diadduct paths there is no certain trend biased toward GG adduct. In addition, the second substitutions of the trans-monoadduct to trans-diadduct paths have lower activation barriers than the corresponding cis-monoadduct to cis-diadduct paths. The lowest activation energy in the bifunctional substitutions from cis-monoadduct to cis-diadduct is 20.5 kcal/mol in the Pt(acetonimine)_2GG~(2+) head-to-head (HH) path, while it is 17.7 kcal/mol from trans-monoadduct to trans-diadduct in the Pt(NH_3)(acetonimine)GA~(2+) head-to-tail (HT) path. For the first and second substitutions, hydrogen-bonds play an important role in stabilizing these species.
机译:使用密度泛函理论和IEF-PCM溶剂化模型,通过计算研究了标题抗肿瘤药物与嘌呤碱基的单官能(第一取代反应)和双官能(第二取代反应)结合。对于鸟嘌呤和腺嘌呤的首次取代,我们的计算表明,反式一水和二水合反应物(RCs)可以通过相同或非常相似的三角-双锥体过渡态结构生成反式或顺式一加合物,预测该顺式一加合物反式RC产生的产物随后可以通过与邻近的嘌呤碱基配位而闭合,形成1,2-链内Pt-DNA加合物,并最终以与顺铂相同的方式使DNA变形。因此,跨铂类似物可能具有与顺铂相同的抗癌活性机制。通常,一水和二水单官能取代优选鸟嘌呤而不是腺嘌呤。在单水取代中(由鸟嘌呤从反式[[Pt {HN = C(CH_3)_2} _2Cl(H_2O)]〜+转化为反式/顺式一加合物的鸟嘌呤取代)计算得出的水溶液中最低的活化自由能为15.2 kcal / mol。 ,以及在diaqua取代中的11.4 kcal / mol(被鸟嘌呤从顺式[[Pt {HN = C(CH_3)2} _2(H_2O)_2]〜(2+)取代为顺式一加合物)。对于第二次取代,所有反应物均由鸟嘌呤取代的第一次取代的diadia产物配合物开始。鸟嘌呤和腺嘌呤RCs之间络合能差的数据表明,在水溶液中,热力学有利于GG的生成而不是GA加合物的生成约5-12 kcal / mol。此外,对于顺式-单加合物至顺式-二价途径,GG相对于GA加合物的形成具有动力学上的偏好,而对于反式-单加合物至跨-二价途径而言,并没有偏向于GG加合物的趋势。另外,与相应的顺式-单加合物至顺式-双还原剂路径相比,反式-单加合物至反式-双还原剂路径的第二取代具有更低的活化势垒。在Pt(乙炔胺)_2GG〜(2+)头对头(HH)路径中,从顺式单加合物到顺式双取代的双功能取代的最低活化能为20.5 kcal / mol,而为17.7 kcal / mol从Pt(NH_3)(乙胺基)GA〜(2+)头到尾(HT)路径从反一加合物转变为反二取代。对于第一和第二取代,氢键在稳定这些物质中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号